Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beneficient (BENF) Cash & Equivalents (2022 - 2025)

Beneficient (BENF) has disclosed Cash & Equivalents for 4 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 89.61% to $7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, up 89.61% year-over-year, with the annual reading at $1.3 million for FY2025, 82.99% down from the prior year.
  • Cash & Equivalents hit $7.9 million in Q4 2025 for Beneficient, up from $4.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $70.6 million in Q1 2022 to a low of $1.3 million in Q1 2025.
  • Historically, Cash & Equivalents has averaged $10.7 million across 4 years, with a median of $4.9 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: tumbled 87.64% in 2023 and later soared 89.61% in 2025.
  • Year by year, Cash & Equivalents stood at $70.6 million in 2022, then crashed by 84.13% to $11.2 million in 2023, then crashed by 62.96% to $4.1 million in 2024, then skyrocketed by 89.61% to $7.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for BENF at $7.9 million in Q4 2025, $4.9 million in Q3 2025, and $7.6 million in Q2 2025.